Nakagawa J, Kinjo T, Aiuchi N, Ueno K, Tomita H, Niioka T. Effect of pregnane X receptor and cytochrome P450 oxidoreductase gene polymorphisms on trough concentrations of rivaroxaban and edoxaban in patients with nonvalvular atrial fibrillation. Eur J Clin Pharmacol. 2023 May;79(5):703-705. doi: 10.1007/s00228-023-03483-7. Epub 2023 Mar 23. PMID: 36951964.
Nakagawa J, Takahata T, Chen Y, Saito K, Kamata K, Tachita T, Yamashita S, Saito K, Ueno K, Sato A, Sakuraba H, Niioka T. Influence of CYP3A5 and ABCB1 polymorphisms on the pharmacokinetics of vincristine in adult patients receiving CHOP therapy. Cancer Chemother Pharmacol. 2023 Nov;92(5):391-398. doi: 10.1007/s00280-023-04580-1. Epub 2023 Aug 23. PMID: 37610625.
Yokoyama S, Nakagawa J, Kudo M, et al: Impact of solute carrier transporter gene polymorphisms on serum creatinine concentrations in healthy volunteers.
Pharmacol Res Perspect. 2023;11(1):e01048.
Kanda T, Wakiya T, Ishido K, Kimura N, Nagase H, Yoshida E, Nakagawa J, Matsuzaka M, Niioka T, Sasaki Y, Hakamada K. Noninvasive Computed Tomography-Based Deep Learning Model Predicts In Vitro Chemosensitivity Assay Results in Pancreatic Cancer. Pancreas. 2024 Jan 1;53(1):e55-e61. doi: 10.1097/MPA.0000000000002270. Epub 2023 Nov 24. PMID: 38019604.
横山智士: トリメトプリム-スルファメトキサゾールのtherapeutic drug monitoringの意義(シンポジウム), 第39回日本TDM学会・学術大会(京都), 2023.6.
齋藤圭悟, 中川潤一, 髙畑武功, 陳豫, 齋藤絢介, 鎌田耕輔, 立田卓登. 上野桂代, 佐藤温, 櫻庭裕丈, 新岡丈典: Effect of CBR3 730G>A polymorphism on the pharmacokinetics of doxorubicin and doxorubicinol, 第39回日本TDM学会・学術大会(京都), 2023.6.